IFP Advisors’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345 Buy
22
+2
+10% +$24 ﹤0.01% 4758
2026
Q1
$200 Hold
20
﹤0.01% 4618
2025
Q4
$609 Hold
20
﹤0.01% 4230
2025
Q3
$397 Hold
20
﹤0.01% 4243
2025
Q2
$291 Buy
+20
New +$283 ﹤0.01% 4562

Other funds holding BBNX

IFP Advisors's BBNX Position: Q2 2026 in Review

IFP Advisors increased its Beta Bionics (BBNX) stake by 10% in Q2 2026, buying an estimated $24 and bringing the position to 22 shares worth $345. The position accounts for ﹤0.01% of the portfolio, ranked #4758.

IFP Advisors first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $609 in Q4 2025. 19 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • IFP Advisors held 22 shares of Beta Bionics worth $345 as of Q2 2026.
  • IFP Advisors bought 2 Beta Bionics shares in Q2 2026, an estimated $24.
  • Beta Bionics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4758 holding.
  • IFP Advisors first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • IFP Advisors's Beta Bionics position peaked at $609 in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.